Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology

Blanca Bolea-Alamañac (Lead / Corresponding author), David J. Nutt, Marios Adamou, Phillip Asherson, Stephen Bazire, David Coghill, David Heal, Ulrich Müller, John Nash, Paramala Santosh, Kapil Sayal, Edmund Sonuga-Barke, Susan J. Young, Consensus Group

    Research output: Contribution to journalArticle

    141 Citations (Scopus)

    Abstract

    Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal burden. The present guidelines summarise current literature, generating expert consensus recommendations for the treatment of ADHD in children and adults. These guidelines also provide a review of recent research in the fields of neuroimaging, neuropsychology and genetics of ADHD. Novel discoveries in these areas have informed physiological models for the disease. Since the publication of the previous British Association for Psychopharmacology guidelines in 2008, new drugs have been licensed and further compounds are being investigated. The publication of randomised controlled trials of psychological interventions has contributed to the range of treatment options for ADHD. As the disorder has been diagnosed more frequently there has been greater focus on comorbid conditions and how they impact treatment. Services have continued to develop for the treatment of ADHD in adults and care agreements have been introduced to facilitate access to treatment.
    Original languageEnglish
    Pages (from-to)179-203
    Number of pages25
    JournalJournal of Psychopharmacology
    Volume28
    Issue number3
    Early online date12 Feb 2014
    DOIs
    Publication statusPublished - Mar 2014

    Fingerprint Dive into the research topics of 'Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology'. Together they form a unique fingerprint.

  • Cite this

    Bolea-Alamañac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Müller, U., Nash, J., Santosh, P., Sayal, K., Sonuga-Barke, E., Young, S. J., & Consensus Group (2014). Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 28(3), 179-203. https://doi.org/10.1177/0269881113519509